SWAN Announces Follow-On Investment in ClearFlame Engine Technologies

The SWAN Impact Network is pleased to announce a recent follow-on investment in ClearFlame Engine Technologies, part of a larger raise of $30M in Series B funding for the company.

The latest investments were led by Mercuria Energy Group, one of the world’s largest privately held energy and commodities companies, with Mercuria and Breakthrough Energy Ventures both making second investments. New investors, including mining corporation Rio Tinto, and WIND Ventures, the strategic venture arm of Copec, one of Latin America’s leading mobility and energy companies, see ClearFlame as part of a holistic suite of strategies to advance environmental, social and governance (ESG) goals.

ClearFlame Engine Technologies significantly reduces GHG emissions for long-haul trucking, agriculture, power generation, and other sectors by transforming heavy-duty engines to run more cost-effectively and cleaner on 100% renewable, plant-based fuels.

SWAN previously invested in ClearFlame Engine Technologies in 2020 and 2021.

SWAN announces investment in Relavo

SWAN is pleased to announce an initial investment in Relavo.

Relavo is a medical device company that is changing the way that kidney failure patients receive treatment. Founded by an all-female team of biomedical engineers from Johns Hopkins University, Relavo is seeking to make home dialysis more accessible by minimizing the risk of infection with their technology, the PeritoneX. The PeritoneX is a novel connection device that reduces the risk of infection in peritoneal dialysis. Rather than connecting tubes directly, patients will connect them to the PeritoneX, which then internally disinfects the connected tubes with an antimicrobial solution. By reducing the risk of infection, patients will receive safer treatment.

SWAN announces follow-on investment in Sonnest

SWAN is pleased to announce a follow-on investment in Sonnest.

Sonnest is transforming cardiac ultrasound. Their Electrast™ is the first electrically sensitive imaging agent for assessing and monitoring the perfusion, structure, and function of the heart, allowing low cost ultrasound procedures to provide information only previously available from much higher cost scans. Electrast™ is a contrast agent that activates with ultrasound and the heart’s local electric field if the heart tissue is perfused and viable.

SWAN previously invested in Sonnest in February and May 2021.

SWAN announces investment in Young Mountain Tea

SWAN is pleased to announce an initial investment in Young Mountain Tea.

Young Mountain Tea works directly with tea farmers in India and Nepal to create organic tea, allowing the company to meet consumer demand for transparency and authentic impact. Right now, American consumers can’t access sustainable tea because existing tea companies buy corporate-grown tea through long chains of intermediaries. Tea has the potential to transform life for Himalayan tea farmers by creating sustainable livelihoods and repairing damaged ecosystems. Young Mountain Tea also partners with farmers to also help build factories to help process the tea, which the otherwise cash-strapped farmers would not be able to build.

1 2 3 4 6